Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2018

Industry: 

560 Views
Buy This Report

Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Spinal Muscular Atrophy (SMA) (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

  • 560 reads